Homing of Super Paramagnetic Iron Oxide Nanoparticles (SPIONs) Labeled Adipose-Derived Stem Cells by Magnetic Attraction in a Rat Model of Parkinson’s Disease

References

• Cui Y, Yang Z, Teasdale RD. The functional roles of retromer in Parkinson’s disease. FEBS Lett. 2018;592(7):1096–1112. doi:10.1002/feb2.2018.592.issue-729210454
   PubMed Web of Science ®Google Scholar
• Zhang PL, Chen Y, Zhang CH, Wang YX, Fernandez-Funez P. Genetics of Parkinson’s disease and related disorders. J Med Genet. 2018;55(2):73–80. doi:10.1136/jmedgenet-2017-10504729151060
   PubMed Web of Science ®Google Scholar
• Alexoudi A, Alexoudi I, Gatzonis S. Parkinson’s disease pathogenesis, evolution and alternative pathways: A review. Rev Neurol (Paris). 2018;174(10):699–704. doi:10.1016/j.neurol.2017.12.00330131173
   PubMed Web of Science ®Google Scholar
• Kordower JH, Burke RE. Disease modification for parkinson’s disease: axonal regeneration and trophic factors. Mov Disord. 2018;33(5):678–683. doi:10.1002/mds.v33.529603370
   PubMed Web of Science ®Google Scholar
• Surmeier DJ. Determinants of dopaminergic neuron loss in Parkinson’s disease. FEBS J. 2018;285(19):3657–3668. doi:10.1111/febs.2018.285.issue-1930028088
   PubMed Web of Science ®Google Scholar
• Burciu RG, Vaillancourt DE. Imaging of motor cortex physiology in Parkinson’s disease. Mov Disord. 2018;33(11):1688–1699. doi:10.1002/mds.10230280416
   PubMed Web of Science ®Google Scholar
• Grayson M. Parkinson’s disease. Nature. 2016;538(7626):S1. doi:10.1038/538S1a27783582
   PubMed Web of Science ®Google Scholar
• Tarakad A, Jankovic J. Diagnosis and management of Parkinson’s Disease. Semin Neurol. 2017;37(2):118–126. doi:10.1055/s-0037-160188828511252
   PubMed Web of Science ®Google Scholar
• Kirkeby A, Nolbrant S, Tiklova K, et al. Predictive markers guide differentiation to improve graft outcome in clinical translation of hESC-based therapy for Parkinson’s disease. Cell Stem Cell. 2017;20(1):135–148. doi:10.1016/j.stem.2016.09.00428094017
   PubMed Web of Science ®Google Scholar
• Gonzalez R, Garitaonandia I, Poustovoitov M, et al. Neural stem cells derived from human parthenogenetic stem cells engraft and promote recovery in a nonhuman primate model of Parkinson’s disease. Cell Transplant. 2016;25(11):1945–1966. doi:10.3727/096368916X69168227213850
   PubMed Web of Science ®Google Scholar
• Tian LP, Zhang S, Xu L, et al. Selenite benefits embryonic stem cells therapy in Parkinson’s disease. Curr Mol Med. 2012;12(8):1005–1014. doi:10.2174/15665241280248088022804247
   PubMed Web of Science ®Google Scholar
• Chen D, Fu W, Zhuang W, Lv C, Li F, Wang X. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson’s disease. J Neurosci Res. 2017;95(3):907–917. doi:10.1002/jnr.v95.327617772
   PubMed Web of Science ®Google Scholar
• Lebedeva OS, Lagarkova MA. Pluripotent stem cells for modelling and cell therapy of Parkinson’s disease. Biochemistry (Mosc). 2018;83(9):1046–1056. doi:10.1134/S000629791809006730472943
   PubMed Web of Science ®Google Scholar
• Altarche-Xifro W, Di Vicino U, Muñoz-Martin MI, et al. Functional rescue of dopaminergic neuron loss in Parkinson’s disease mice after transplantation of hematopoietic stem and progenitor cells. EBioMedicine. 2016;8:83–95. doi:10.1016/j.ebiom.2016.04.01627428421
   PubMed Web of Science ®Google Scholar
• Minteer D, Marra KG, Rubin JP. Adipose-derived mesenchymal stem cells: biology and potential applications. Adv Biochem Eng Biotechnol. 2013;129:59–71. doi:10.1007/10_2012_14622825719
   PubMed Web of Science ®Google Scholar
• Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249–1260. doi:10.1161/01.RES.0000265074.83288.0917495232
   PubMed Web of Science ®Google Scholar
• Mailey B, Hosseini A, Baker J, et al. Adipose-derived stem cells: methods for isolation and applications for clinical use. Methods Mol Biol. 2014;1210:161–181.25173168
   PubMedGoogle Scholar
• Okubo T, Hayashi D, Yaguchi T, et al. Differentiation of rat adipose tissue-derived stem cells into neuron-like cells by valproic acid, a histone deacetylase inhibitor. Exp Anim. 2016;65(1):45–51. doi:10.1538/expanim.15-003826411320
   PubMed Web of Science ®Google Scholar
• Goudarzi F, Tayebinia H, Karimi J, Habibitabar E, Khodadadi I. Calcium: A novel and efficient inducer of differentiation of adipose-derived stem cells into neuron-like cells. J Cell Physiol. 2018;233(11):8940–8951. doi:10.1002/jcp.2682629870058
   PubMed Web of Science ®Google Scholar
• Adib S, Tiraihi T, Darvishi M, Taheri T, Kazemi H. Cholinergic differentiation of neural stem cells generated from cell aggregates-derived from Human Bone marrow stromal cells. J Tissue Eng Regen Med. 2015;12(1):43–52. doi:10.1007/s13770-014-0019-6
   Google Scholar
• Darvishi M, Tiraihi T, Mesbah-Namin SA, Delshad A, Taheri T. Motor neuron transdifferentiation of neural stem cell from adipose-derived stem cell characterized by differential gene expression. Cell Mol Neurobiol. 2017;37(2):275–289. doi:10.1007/s10571-016-0368-x27107758
   PubMed Web of Science ®Google Scholar
• Xie S, Lu F, Tao K, et al. Efficient generation of functional Schwann cells from adipose derived stem cells in defined conditions. Cell Cycle. 2017;16(6):841–851. doi:10.1080/15384101.2017.130432828296571
   PubMedGoogle Scholar
• Bjorklund LM, Pernaute RS, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A. 2012;99(4):2344–2349. doi:10.1073/pnas.022438099
   Google Scholar
• Wu QY, Li J, Feng ZT, Wang TH. Bone marrow stromal cells of transgenic mice can improve the cognitive ability of an Alzheimer disease rat model. Neurosci Lett. 2007;417(3):281–285. doi:10.1016/j.neulet.2007.02.09217412501
   PubMed Web of Science ®Google Scholar
• Silani V, Fogh I, Ratti A, Sassone J, Ciammola A, Cova L. Stem cells in the treatment of amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler Other Motor Neuron Disord. 2002;3(4):173–181. doi:10.1080/14660820276083900112710505
   PubMed Web of Science ®Google Scholar
• Vaněček V, Zablotskii V, Forostyak S, et al. Highly efficient magnetic targeting of mesenchymal stem cells in spinal cord injury. Int J Nanomedicine. 2012;7:3719–3730. doi:10.2147/IJN.S3282422888231
   PubMed Web of Science ®Google Scholar
• Arbab AS, Jordan EK, Wilson LB, et al. In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther. 2004;15(4):351–360. doi:10.1089/10430340432295950615053860
   PubMed Web of Science ®Google Scholar
• Andreas K, Georgieva R, Ladwig M, et al. Highly efficient magnetic stem cell labeling with citrate-coated superparamagnetic iron oxide nanoparticles for MRI tracking. Biomaterials. 2012;33(18):4515–4525. doi:10.1016/j.biomaterials.2012.02.06422445482
   PubMed Web of Science ®Google Scholar
• Ahn YJ, Kong TH, Choi JS, Yun WS, Key J, Seo YJ. Strategies to enhance efficacy of SPION-labeled stem cell homing by magnetic attraction: a systemic review with meta-analysis. Int J Nanomedicine. 2019;14:4849–4866. doi:10.2147/IJN.S20491031308662
   PubMed Web of Science ®Google Scholar
• Grüll H, Langereis S. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound. J Control Release. 2012;161(2):317–327. doi:10.1016/j.jconrel.2012.04.04122565055
   PubMed Web of Science ®Google Scholar
• Mahmoudi M, Shokrgozar MA, Simchi A, et al. Multiphysics flow modeling and in vitro toxicity of iron oxide nanoparticles coated with poly(vinyl alcohol). J Phys Chem C. 2009;113(6):2322–2331. doi:10.1021/jp809453v
   Web of Science ®Google Scholar
• Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol. 1989;152(1):167–173. doi:10.2214/ajr.152.1.1672783272
   PubMed Web of Science ®Google Scholar
• Longmire M, Choyke PL, Kobayashi H. Dendrimerbased contrast agents for molecular imaging. Curr Top Med Chem. 2008;8(14):1180–1186. doi:10.2174/15680260878584902118855704
   PubMed Web of Science ®Google Scholar
• Yocum GT, Wilson LB, Ashari P, Jordan EK, Frank JA, Arbab AS. Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats. Radiology. 2005;235(2):547–552. doi:10.1148/radiol.235204038315858093
   PubMed Web of Science ®Google Scholar
• Wilhelm C, Gazeau F, Bacri HC. Magnetophoresis and ferromagnetic resonance of magnetically labeled cells. Eur Biophys J. 2002;31(2):118–125. doi:10.1007/s00249-001-0200-412012115
   PubMed Web of Science ®Google Scholar
• Landázuri N, Tong S, Suo J, et al. Magnetic targeting of human mesenchymal stem cells with internalized superparamagnetic iron oxide nanoparticles. Small. 2013;9(23):4017–4026. doi:10.1002/smll.20130057023766267
   PubMed Web of Science ®Google Scholar
• Cheng K, Malliaras K, Li TS, et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/ reperfusion. Cell Transplant. 2012;21(6):1121–1135. doi:10.3727/096368911X62738122405128
   PubMed Web of Science ®Google Scholar
• Yun W, Choi J, Ju H, et al. Enhanced homing technique of mesenchymal stem cells using iron oxide nanoparticles by magnetic attraction in olfactory-injured mouse models. Int J Mol Sci. 2018;19(5):1376. doi:10.3390/ijms19051376
   PubMed Web of Science ®Google Scholar
• Albukhaty S, Naderi-Manesh H, Tiraihi T. In vitro labeling of neural stem cells with poly-l-lysine coated super paramagnetic nanoparticles for green fluorescent protein transfection. Iran Biomed J. 2013;17(2):71–76. doi:10.6091/ibj.1114.201323567848
   PubMedGoogle Scholar
• Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl. 1971;367:69–93. doi:10.1111/j.1365-201X.1971.tb11000.x4332693
   PubMedGoogle Scholar
• Moayeri A, Khalili Z, Darvishi M. Sexually dimorphic effect of Zonisamide on behavioral locomotor activity in a rat model of Parkinson’s disease. Int J Pharm Phytopharm Res. 2019;9(5):19–28.
   Web of Science ®Google Scholar
• Berg DA, Belnoue L, Song H, Simon A. Neurotransmitter-mediated control of neurogenesis in the adult vertebrate brain. Development. 2013;140(12):2548–2561. doi:10.1242/dev.08800523715548
   PubMed Web of Science ®Google Scholar
• Danielyan L, Beer-Hammer S, Stolzing A, et al. Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease. Cell Transplant. 2014;23(1):S123–S139. doi:10.3727/096368914X68497025302802
   PubMedGoogle Scholar
• Okano H, Yamanaka S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol Brain. 2014;7:22. doi:10.1186/1756-6606-7-2224685317
   PubMed Web of Science ®Google Scholar
• Yasuhara T, Matsukawa N, Hara K, et al. Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson’s disease. J Neurosci. 2006;26(48):12497–12511. doi:10.1523/JNEUROSCI.3719-06.200617135412
   PubMed Web of Science ®Google Scholar
• Pluchino S, Zanotti L, Rossi B, et al. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature. 2005;436(7048):266–271. doi:10.1038/nature0388916015332
   PubMed Web of Science ®Google Scholar
• Baer PC, Geiger H. Adipose-derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int. 2012;2012:812693. doi:10.1155/2012/81269322577397
   PubMed Web of Science ®Google Scholar
• Tapp H, Hanley EN Jr, Patt JC, Gruber HE. Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med (Maywood). 2009;234(1):1–9. doi:10.3181/0805-MR-17019109553
   PubMed Web of Science ®Google Scholar
• François S, Bensidhoum M, Mouiseddine M, et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells. 2006;24(4):1020–1029. doi:10.1634/stemcells.2005-026016339642
   PubMed Web of Science ®Google Scholar
• Van der Meeren A, Mouthon MA, Vandamme M, Squiban C, Aigueperse J. Combinations of cytokines promote survival of mice and limit acute radiation damage in concert with amelioration of vascular damage. Radiat Res. 2004;161(5):549–559. doi:10.1667/RR316415161368
   PubMed Web of Science ®Google Scholar
• Kandasamy G, Maity D. Recent advances in super paramagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics. Int J Pharm. 2015;496:191–218. doi:10.1016/j.ijpharm.2015.10.05826520409
   PubMed Web of Science ®Google Scholar
• Ahmad J, Akhter S, Rizwanullah M, et al. Nanotechnology based theranostic approaches in Alzheimer’s disease management: current status and future perspective. Curr Alzheimer Res. 2017;14(11):1164–1181. doi:10.2174/156720501466617050812103128482786
   PubMed Web of Science ®Google Scholar
• Kaushik A, Kumar A, Peng Z, et al. Evaluation and validation of synergistic effects of amyloid-beta inhibitor–gold nanoparticles complex on Alzheimer’s disease using deep neural network approach. J Mater Res. 2019;34(11):1845–1853. doi:10.1557/jmr.2018.452
   Web of Science ®Google Scholar
• Kaushik AC, Kumar A, Dwivedi VD, et al. Deciphering the biochemical pathway and pharmacokinetic study of amyloid βeta-42 with Superparamagnetic Iron Oxide Nanoparticles (SPIONs) using systems biology approach. Mol Neurobiol. 2018;55(4):3224–3236. doi:10.1007/s12035-017-0546-y28478508
   PubMed Web of Science ®Google Scholar
• Shen WB, Plachez C, Tsymbalyuk O, et al. Cell-based therapy in TBI: magnetic retention of neural stem cells in vivo. Cell Transplant. 2016;25(6):1085–1099. doi:10.3727/096368915X68955026395573
   PubMed Web of Science ®Google Scholar
• Kaushik AC, Bharadwaj S, Kumar S, Wei DQ. Nano-particle mediated inhibition of Parkinson’s disease using computational biology approach. Sci Rep. 2018;8(1):9169. doi:10.1038/s41598-018-27580-129907754
   PubMedGoogle Scholar
• Apopa PL, Qian Y, Shao R, et al. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part Fibre Toxicol. 2009;6:1. doi:10.1186/1743-8977-6-119134195
   PubMed Web of Science ®Google Scholar
• Huang G, Chen H, Dong Y, et al. Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics. 2013;3(2):116–126. doi:10.7150/thno.541123423156
   PubMed Web of Science ®Google Scholar
• Huang DM, Hsiao JK, Chen YC, et al. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials. 2009;30(22):3645–3651. doi:10.1016/j.biomaterials.2009.03.03219359036
   PubMed Web of Science ®Google Scholar
• Gokduman K, Bestepe F, Li L, Yarmush ML, Usta OB. Dose-, treatment- and time-dependent toxicity of superparamagnetic iron oxide nanoparticles on primary rat hepatocytes. Nanomedicine (Lond). 2018;13(11):1267–1284. doi:10.2217/nnm-2017-038729949471
   PubMed Web of Science ®Google Scholar
• Ankamwar B, Lai TC, Huang JH, et al. Biocompatibility of Fe(3)O(4) nanoparticles evaluated by in vitro cytotoxicity assays using normal, glia and breast cancer cells. Nanotechnology. 2010;21(7):75102. doi:10.1088/0957-4484/21/7/07510220090199
   PubMed Web of Science ®Google Scholar
• Sapet C, Laurent N, de Chevigny A, et al. High transfection efficiency of neural stem cells with magnetofection. Biotechniques. 2011;50(3):187–189. doi:10.2144/00011362821486240
   PubMed Web of Science ®Google Scholar
• Hartono SB, Gu W, Kleitz F, et al. Poly-L-lysine functionalized large pore cubic mesostructured silica nanoparticles as biocompatible carriers for gene delivery. ACS Nano. 2012;6(3):2104–2117. doi:10.1021/nn203964322385282
   PubMed Web of Science ®Google Scholar
• Tarulli E, Chaudhuri JD, Gretka V, Hoyles A, Morshead CM, Stanisz GJ. Effectiveness of micron-sized superparamagnetic iron oxide particles as markers for detection of migration of bone marrow-derived mesenchymal stromal cells in a stroke model. J Magn Reson Imaging. 2013;37:1409–1418. doi:10.1002/jmri.2389723712844
   PubMed Web of Science ®Google Scholar
• Arora S, Jyutika MR, Kishore MP. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol. 2012;258:151–165. doi:10.1016/j.taap.2011.11.01022178382
   PubMed Web of Science ®Google Scholar
• Hoehn M, Küstermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A. 2002;99(25):16267–16272. doi:10.1073/pnas.24243549912444255
   PubMed Web of Science ®Google Scholar
• Laurent S, Mahmoudi M. Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer. Int J Mol Epidemiol Genet. 2011;2(4):367–390.22199999
   PubMedGoogle Scholar
• Song M, Kim YJ, Kim YH, Roh J, Kim SU, Yoon BW. Using a neodymium magnet to target delivery of ferumoxide-labeled human neural stem cells in a rat model of focal cerebral ischemia. Hum Gene Ther. 2010;21(5):603–610. doi:10.1089/hum.2009.14420059319
   PubMed Web of Science ®Google Scholar
• Marycz K, Kornicka K, Röcken M. Static Magnetic Field (SMF) as a regulator of stem cell fate - new perspectives in regenerative medicine arising from an underestimated tool. Stem Cell Rev Rep. 2018;14(6):785–792. doi:10.1007/s12015-018-9847-430225821
   PubMed Web of Science ®Google Scholar